Adaptimmune Therapeutics plc (ADAP) tumbled -7.06% or -0.47 to $6.19. It is approximately 672362 shares traded, which is 98.51% compare to the average total volume 682525. The market cap of ADAP is $647.29 million. The year to date change is -13.25%. The 52 week price range is from $5.73 to $14.62. Price of ADAP have changed -6.06% during last week. It have changed -49.55% over last month, -25.00% over last 3 months, -49.96% over last 6 months and -18.48% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ADAP is 10.50. It is 69.63% above current price. The 200-day Moving Averages for ADAP is 10.68. It is 72.54% above current price. The 52-week High is 14.62. It is 136.19% from the current price. The 52-week Low is 5.73. It is -7.43% from current price.
There are some statistics of ADAP. It is has market cap $647.29 million. The share outstanding is 104.57 million. The average volume is 682525. The percent of top 15 Institution holding is 14.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ADAP is -34.45%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ADAP is -28.49%.